サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768948

食道ステントの世界市場

Esophageal Stents

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
食道ステントの世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

食道ステントの世界市場は2030年までに1億2,270万米ドルに達する見込み

2024年に8,910万米ドルと推定される食道ステントの世界市場は、2024年から2030年にかけてCAGR 5.5%で成長し、2030年には1億2,270万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである病院は、CAGR 5.8%を記録し、分析期間終了時には8,150万米ドルに達すると予測されます。専門クリニックの成長率は、分析期間中CAGR 5.1%と推定されます。

米国市場は2,320万米ドルと推定、中国はCAGR8.4％で成長予測

米国の食道ステント市場は、2024年に2,320万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 8.4%で推移し、2030年には予測市場規模2,760万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と4.5％と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の食道ステント市場- 主要動向と促進要因のまとめ

食道ステントとは何か？

食道ステントは、悪性腫瘍や良性狭窄、その他の解剖学的異常による食道閉塞を患う患者の内腔開存性を維持するために食道に挿入されるチューブ状の器具です。患者のQOLや栄養状態に深刻な影響を与える嚥下障害などの症状を緩和する上で、重要な役割を担っています。食道ステントは通常、腫瘍が食物の通過を阻害する食道がんの症例や、長時間の酸への曝露とそれに続く瘢痕組織の形成によって生じる消化性狭窄などの良性疾患において使用されます。また、気管食道瘻や食道穿孔のような合併症の治療にも使用され、より確実な治療への橋渡しとして、あるいは患者の快適性を高めるための緩和的手段として用いられます。食道ステントは、自己拡張を可能にする柔軟な合金であるニチノールや、組織の浸潤を防ぐシリコンで覆われた金属など、様々な材料から作られています。これらのステントには被覆型と非被覆型があり、被覆型ステントは腫瘍の内腔への進展を阻止し、漏れを管理するように設計されており、非被覆型ステントは良性の狭窄の場合に、より強固な固定を提供します。臨床シナリオに応じて、ステント留置は内視鏡的または透視下ガイド下で行われ、即時の症状緩和と経口摂取の回復を目指します。多用途かつ低侵襲なソリューションとして、食道ステントは複雑な食道疾患の管理に不可欠な選択肢となり、治療と緩和の両方のメリットを提供しています。

技術の進歩は食道ステントの機能をどのように向上させていますか？

技術の進歩は、食道ステントのデザインとアプリケーションに革命をもたらし、安全性、有効性、そして患者の転帰を向上させました。最も重要な開発のひとつは、完全被覆自己拡張型金属ステント（SEMS）の導入で、腫瘍の進展や食物の挟み込みなどの合併症を減少させながら、最適なサポートを提供します。超弾性および形状記憶特性で知られるニチノールのような先端材料の使用により、メーカーは食道の不規則な解剖学的構造に正確に適合するステントを作成できるようになり、移動のリスクを最小限に抑え、患者の快適性を最大限に高めることができるようになりました。一部のステントは逆流防止弁を備えており、悪性狭窄患者によく見られる胃食道逆流を防止することで、術後のQOLを向上させています。シリコーンやポリウレタンなどのコーティング材料の革新も極めて重要であり、バイオフィルムの形成を抑え、ステントの閉塞を防ぐ滑らかな内面を提供しています。さらに、薬剤溶出技術が食道ステントに統合されたことも最近の画期的な出来事です。これらのステントは化学療法剤や抗増殖剤でコーティングされており、組織の過形成や狭窄の再発を防ぎ、ステントの機能的寿命を延長します。もうひとつの主な発展は生分解性ステントの開発で、このステントは時間の経過とともに徐々に溶解するため、抜去処置を必要としない良性疾患の治療に最適です。ステント送達システムの改良も、ステント留置の精度と安全性の向上に寄与しています。最新のデリバリー・システムは、制御された放出機構、より良好な可視化のための放射線透過性の向上、あらかじめ装填されたガイドワイヤーなどの機能を備えており、内視鏡医が困難な解剖学的構造であっても、より正確にステントを配置できるようになっています。このような技術的進歩により、食道ステントは、より幅広い食道疾患に、より少ない合併症で対応する高度に洗練された機器へと変貌しつつあります。

患者層や治療アプローチの変化は食道ステント市場にどのような影響を与えているか？

食道ステント市場は、患者の人口統計の変化、食道がんの有病率の上昇、治療パラダイムのシフトによって急速に発展しています。食道がん、特に胃食道逆流症（GERD）や肥満に関連した腺がんの世界の増加により、食道ステントのような効果的な緩和ソリューションに対する需要が高まっています。悪性・良性両方の食道疾患に罹患しやすい高齢化社会は、栄養摂取を確保し、嚥下障害を軽減する長期的な管理オプションの必要性をさらに高めています。このような人口動態の変化により、ヘルスケアプロバイダーはQOLを高める介入を優先するようになり、食道ステント留置術は手術不能ながん症例における緩和ケアとして好ましい選択肢となっています。同時に、治療アプローチの変化も市場に影響を与えています。例えば、合併症のリスク軽減、回復時間の短縮、内視鏡的手技に関連する低コストなどの理由から、より侵襲的な外科的手技よりも内視鏡的ステント留置術が好まれるようになってきています。このため、悪性症例だけでなく、良性の狭窄、難治性の食道静脈瘤、術後の吻合部リークの治療にも使用されるようになっています。さらに、患者中心の治療モデルが製品開発を形成しつつあり、挿入が容易で、患者の忍容性が高く、術後の合併症が少ないステントが重視されるようになってきています。このシフトにより、固定力の向上、潰瘍形成抑制のための柔らかい素材、最適な位置決めを確実にする革新的な移動防止機能を備えたステントが設計されるようになりました。新興市場では低侵襲ステント留置術の採用が増加していることも成長を後押ししています。これらの地域ではヘルスケアへの投資が増加し、食道疾患に対する高度な治療オプションに対する認識が高まっているからです。

食道ステント市場の主な成長促進要因は？

食道ステント市場の成長は、食道がんの罹患率の上昇、ステント技術の進歩、低侵襲治療の採用増加など、いくつかの重要な要因によってもたらされます。特に先進諸国では、喫煙、多量のアルコール摂取、慢性的な酸の逆流などの生活習慣が食道がんの発生率を高めています。このため、嚥下障害を緩和し、進行がん患者のQOLを高める緩和ケアの必要性が高まっています。柔軟性と抗移行性を強化した自己拡張型金属ステントの開発などの技術革新も、食道ステントの臨床応用を拡大する上で極めて重要な役割を果たしています。薬剤溶出性ステントや生分解性ステントを組み込むことで、良性疾患の管理や再狭窄予防のための新たな治療オプションが提供され、市場の需要をさらに押し上げています。もう一つの大きな成長要因は、従来の手術よりも侵襲性が低く、回復に要する時間も早い内視鏡手術の普及です。より多くのヘルスケアプロバイダーが内視鏡的ステント留置術を悪性・良性食道閉塞治療の標準的アプローチとして採用するにつれて、先進ステントに対する需要が急増しています。さらに、新興市場におけるヘルスケアインフラの拡大、医療費の増加、食道疾患の有病率の上昇が市場成長の新たな機会を生み出しています。価値観に基づくヘルスケアへの動向も、長期予後の改善と合併症発生率の減少をもたらし、食道疾患管理における費用対効果の高いソリューションとなるステントへの関心を高めています。このような市場促進要因は食道ステント市場に変革をもたらし、世界中のヘルスケアシステムが食道疾患に対する低侵襲的ソリューションを優先し続ける中で、食道ステント市場は持続的な拡大が期待できます。

セグメント

エンドユーザー（病院、専門クリニック、外来手術センター）

調査対象企業の例

  • Andratec GmbH
  • Boston Scientific Corporation
  • BVM Medical Limited
  • C. R. Bard, Inc.
  • Cook Group Incorporated
  • Ella-CS, s.r.o.
  • Endo-Flex GmbH
  • M.I.Tech
  • Merit Medical Systems, Inc.
  • Taewoong Medical Co., Ltd.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17707

Global Esophageal Stents Market to Reach US$122.7 Million by 2030

The global market for Esophageal Stents estimated at US$89.1 Million in the year 2024, is expected to reach US$122.7 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$81.5 Million by the end of the analysis period. Growth in the Specialty Clinics segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$23.2 Million While China is Forecast to Grow at 8.4% CAGR

The Esophageal Stents market in the U.S. is estimated at US$23.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Esophageal Stents Market - Key Trends and Drivers Summarized

What Are Esophageal Stents and Why Are They Used?

Esophageal stents are tubular devices inserted into the esophagus to maintain luminal patency in patients suffering from esophageal obstructions caused by malignant tumors, benign strictures, or other anatomical abnormalities. They play a critical role in alleviating symptoms like dysphagia (difficulty swallowing), which can severely impact a patient’s quality of life and nutritional status. Esophageal stents are typically used in cases of esophageal cancer, where the tumor obstructs the passage of food, or in benign conditions such as peptic strictures, which result from prolonged acid exposure and subsequent scar tissue formation. They can also be utilized to manage complications like tracheoesophageal fistulas or esophageal perforations, serving as a bridge to more definitive treatment or as a palliative measure to enhance the patient’s comfort. Esophageal stents are made from various materials such as nitinol, a flexible alloy that allows for self-expansion, or silicone-covered metal, which helps prevent tissue ingrowth. These stents come in both covered and uncovered variants: covered stents are designed to block tumor growth into the lumen and manage leaks, while uncovered stents provide a firmer anchorage in cases of benign strictures. Depending on the clinical scenario, stent placement can be performed endoscopically or under fluoroscopic guidance, with the aim of immediate symptomatic relief and the restoration of oral intake. As a versatile and minimally invasive solution, esophageal stents have become an essential option in managing complex esophageal conditions, offering both therapeutic and palliative benefits.

How Are Technological Advancements Improving the Functionality of Esophageal Stents?

Technological advancements have revolutionized the design and application of esophageal stents, enhancing their safety, effectiveness, and overall patient outcomes. One of the most significant developments is the introduction of fully covered self-expanding metal stents (SEMS), which provide optimal support while reducing complications such as tumor ingrowth and food impaction. The use of advanced materials like nitinol, known for its superelasticity and shape memory properties, has allowed manufacturers to create stents that conform precisely to the irregular anatomy of the esophagus, minimizing the risk of migration and maximizing patient comfort. Some stents now feature anti-reflux valves, which prevent gastroesophageal reflux-a common issue in patients with malignant strictures-thus improving their quality of life post-procedure. Innovations in coating materials, such as silicone or polyurethane, have also been pivotal, providing a smooth inner surface that reduces biofilm formation and prevents stent obstruction. Moreover, the integration of drug-eluting technology into esophageal stents is a recent breakthrough. These stents are coated with chemotherapeutic agents or anti-proliferative drugs to prevent tissue hyperplasia and recurrent stricture formation, extending the functional lifespan of the stent. Another key advancement is the development of biodegradable stents, which gradually dissolve over time, making them ideal for treating benign conditions without the need for removal procedures. Improvements in stent delivery systems have also contributed to the increased precision and safety of stent placement. Modern delivery systems are equipped with features such as controlled release mechanisms, enhanced radiopacity for better visualization, and preloaded guidewires, enabling endoscopists to deploy stents more accurately even in challenging anatomies. These technological strides are transforming esophageal stents into highly sophisticated devices that address a broader range of esophageal disorders with fewer complications.

How Are Shifting Patient Demographics and Treatment Approaches Impacting the Esophageal Stent Market?

The esophageal stent market is evolving rapidly, driven by changes in patient demographics, rising prevalence of esophageal cancers, and shifts in treatment paradigms. The global increase in esophageal cancer cases, especially adenocarcinoma linked to gastroesophageal reflux disease (GERD) and obesity, has led to a heightened demand for effective palliative solutions like esophageal stents. An aging population, which is more susceptible to both malignant and benign esophageal conditions, has further fueled the need for long-term management options that can ensure nutritional intake and reduce dysphagia. This demographic shift has prompted healthcare providers to prioritize interventions that enhance the quality of life, making esophageal stenting a preferred choice for palliative care in inoperable cancer cases. Simultaneously, changes in treatment approaches are also influencing the market. For instance, there is an increasing preference for endoscopic stenting over more invasive surgical procedures due to the reduced risk of complications, shorter recovery times, and lower costs associated with endoscopic techniques. This has expanded the use of esophageal stents in not only malignant cases but also in treating benign strictures, refractory esophageal varices, and postoperative anastomotic leaks. Moreover, patient-centric care models are shaping product development, with a growing emphasis on stents that offer ease of insertion, better patient tolerance, and minimal post-procedure complications. This shift has led to the design of stents with improved anchorage, softer materials to reduce ulceration, and innovative anti-migration features that ensure optimal positioning. The increasing adoption of minimally invasive stenting procedures in emerging markets is also driving growth, as these regions experience rising healthcare investment and a growing awareness of advanced treatment options for esophageal conditions.

What Are the Key Growth Drivers in the Esophageal Stent Market?

The growth in the esophageal stent market is driven by several critical factors, including the rising incidence of esophageal cancer, advancements in stent technology, and the increasing adoption of minimally invasive treatments. One of the primary drivers is the global surge in esophageal cancer cases, particularly in developed countries, where lifestyle factors such as smoking, heavy alcohol use, and chronic acid reflux have contributed to a higher incidence of adenocarcinoma. This has led to an increased need for palliative care options that can alleviate dysphagia and enhance the quality of life for patients in advanced stages of cancer. Technological innovations, such as the development of self-expanding metal stents with enhanced flexibility and anti-migration properties, are also playing a pivotal role in expanding the clinical applications of esophageal stents. The incorporation of drug-eluting and biodegradable stents is providing new therapeutic options for managing benign conditions and preventing restenosis, further boosting market demand. Another significant growth driver is the widespread adoption of endoscopic procedures, which are less invasive than traditional surgery and associated with faster recovery times. As more healthcare providers embrace endoscopic stenting as the standard approach for treating both malignant and benign esophageal obstructions, the demand for advanced stents has surged. Furthermore, the expansion of healthcare infrastructure in emerging markets, along with increased healthcare expenditure and the rising prevalence of esophageal disorders, is creating new opportunities for market growth. The trend toward value-based healthcare is also driving interest in stents that offer improved long-term outcomes and reduced complication rates, making them a cost-effective solution in the management of esophageal diseases. These diverse growth drivers are transforming the esophageal stent market, positioning it for sustained expansion as healthcare systems worldwide continue to prioritize minimally invasive solutions for esophageal pathologies.

SCOPE OF STUDY:

The report analyzes the Esophageal Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Andratec GmbH
  • Boston Scientific Corporation
  • BVM Medical Limited
  • C. R. Bard, Inc.
  • Cook Group Incorporated
  • Ella - CS, s.r.o.
  • Endo-Flex GmbH
  • M.I.Tech
  • Merit Medical Systems, Inc.
  • Taewoong Medical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Esophageal Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Esophageal Cancers Throws the Spotlight on Stenting as a Palliative Solution
    • Growing Adoption of Minimally Invasive Treatments Propels Demand for Esophageal Stents
    • Here's How Technological Advancements in Stent Design Strengthen the Business Case for Adoption
    • Expanding Use of Self-Expanding Metal Stents Drives Market Growth with Enhanced Clinical Outcomes
    • Increasing Preference for Endoscopic Procedures Generates Demand for Esophageal Stenting
    • Here's the Story: Rising Geriatric Population Sustains Growth in Demand for Dysphagia Management
    • Innovations in Anti-Migration and Anti-Reflux Features Expand the Addressable Market
    • Growing Incidence of Esophageal Strictures Spurs Demand for Safe and Effective Stent Solutions
    • Trend Toward Bioabsorbable Stents Expands Market Opportunity in Short-Term Therapeutic Applications
    • Here's How Increasing Use in Benign Conditions Generates New Market Opportunities
    • Rising Incidence of Gastroesophageal Reflux Disease (GERD) Creates Niche Growth Potential
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Esophageal Stents Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION